. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database. Alzheimers Res Ther. 2017 Apr 26;9(1):32. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(124)
137 ± 38
ng/L
xMAP;
INNO-BIA AlzBio3;
Innogenetics
McKhann et al., 1984; Dubois et al., 2007
Aβ42
(CSF)
CTRL-
CNC
(157)
196 ± 50
ng/L
xMAP;
INNO-BIA AlzBio3;
Innogenetics
tau-p181
(CSF)
AD
(124)
60 ± 35
ng/L
xMAP;
INNO-BIA AlzBio3;
Innogenetics
McKhann et al., 1984; Dubois et al., 2007
tau-p181
(CSF)
CTRL-
CNC
(157)
33 ± 16
ng/L
xMAP;
INNO-BIA AlzBio3;
Innogenetics
tau-total
(CSF)
AD
(124)
133 ± 65
ng/L
xMAP;
INNO-BIA AlzBio3;
Innogenetics
McKhann et al., 1984; Dubois et al., 2007
tau-total
(CSF)
CTRL-
CNC
(157)
67 ± 34
ng/L
xMAP;
INNO-BIA AlzBio3;
Innogenetics

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.